Process Development

Oct 30, 2018
By Pharmaceutical Technology Editors
The acquisition will allow Lonza to further develop technology for scalable autologous cell-therapy manufacturing.
Oct 09, 2018
By Pharmaceutical Technology Editors
Syngene International’s Jegadeesh Thampi will discuss the significance of engineering data generation to develop robust, safe, and reproducible processes on Oct. 11, 2018 at CPhI Worldwide.
Oct 01, 2018
By Pharmaceutical Technology Editors
The companies partnered to build a 500-L single-use pilot-scale plant for biologics production.
Sep 27, 2018
By Pharmaceutical Technology Editors
GE Healthcare, Cobra Biologics, and the Centre for Process Innovation (CPI) have entered into a collaboration to advance manufacturing of adeno-associated virus vectors for gene therapy.
Sep 20, 2018
By Pharmaceutical Technology Editors
The CHF 400-million (US$416-million) investment in Lonza's biopark in Visp, Switzerland, will expand Ibex Solutions with two new offerings, drug substance development and drug substance and drug product manufacturing.
Aug 24, 2018
By Pharmaceutical Technology Editors
The new Testa Center in Uppsala, Sweden is a collaborative test bed offering biotechnology equipment from GE Healthcare for process development.
Aug 08, 2018
Pharmaceutical Technology's In the Lab eNewsletter
By Pharmaceutical Technology Editors
Avalon and Weill will co-develop bio-production and standardization procedures for CAR-T therapy.
Jul 19, 2018
By Pharmaceutical Technology Editors
The company has run into a snag in producing Kymriah for the diffuse large B-cell lymphoma patient population, the second indication for which the therapy was recently approved by FDA.
Jul 02, 2018
Pharmaceutical Technology
Traditional barriers between upstream and downstream bioprocessing are slowly starting to break down, as biopharma embraces more advanced analytics and process control.
Jun 08, 2018
By Pharmaceutical Technology Editors
MilliporeSigma targets emerging biotechs with US development center and global grants.
native1_300x100
lorem ipsum